Jasbir S. Seehra
President, CEO & DirectorDr. Jasbir S. Seehra, also known as Jas, Ph.D., is President of Keros Therapeutics, Inc. from August 18, 2025 and has been its Chief Executive Officer and Director since December 2015 and was its Chair of the Board since July 1, 2024 until August 18, 2025 and was its President from December 2015 to June 30, 2024. Dr. Seehra had been Treasurer and Secretary at Keros Therapeutics, Inc. Dr. Seehra had been an Independent Director of Eloxx Pharmaceuticals, Inc. since February 2018 until July 2022. He served as Chief Scientific Officer of Ember Therapeutics, Inc. from December 2011 to April 2015. Dr. Seehra Co-Founded Acceleron Pharma, Inc. in 2003 and served as its Chief Scientific Officer and Senior Vice President from February 2004 to November 2010. Dr. Seehra has experience in drug discovery. He served as Bench Scientist at Genetics Institute since Joined in 1983. Dr. Seehra successfully built the small molecule drug discovery capability at Genetics Institute including medicinal chemistry, high throughput screening and structural biology. Dr. Seehra was responsible for the small molecule lead discovery effort, which included high throughput screening and structural biology. He served as Vice President of Biological Chemistry at Wyeth Pharmaceuticals Inc. in 1999. He served as a Drug Discovery Consultant at GenPath Pharmaceuticals (AVEO Pharmaceuticals). He served as a Member of Scientific Advisory Board at Ember Therapeutics, Inc. He served as Member of Scientific Advisory Board at Acceleron Pharma, Inc. Dr. Seehra has authored numerous publications and is an inventor on 28 patents. He worked for Third Rock Ventures and helped establish Decibel (where he still serves on their Scientific Advisory Board). He received his undergraduate, BS and Ph.D. in Biochemistry from the University of Southampton UK. He completed his postdoctoral work at the Massachusetts Institute of Technology.
Positions
- Company NameKeros Therapeutics, Inc.Stock CodeKROSPositionPresident, CEO & DirectorColleagues
- JBJean-Jacques BienaimeIndependent Chair of the Board
- ECEsther ChoChief Legal Officer & Secretary
- ATAnnita TaniniVP of Finance, Corporate Controller and Interim Principal Financial & Accounting Officer
- JFJustin FrantzHead of Investor Relations
- LLLorena LernerChief Scientific Officer
- MAMary Ann GrayIndependent Director
- AHAlpna Hansraj SethIndependent Director
- JKJulius KnowlesIndependent Director
